Psychopharmacologic treatment of eating disorders: emerging findings

Current Psychiatry Reports
Susan L McElroyPaul E Keck

Abstract

Psychopharmacologic treatment is playing a greater role in the management of patients with eating disorders. In this paper, we review randomized, placebo-controlled trials (RCTs) conducted in anorexia nervosa (AN), bulimia nervosa (BN), binge eating disorder (BED), and other eating disorders over the past 3 years. Fluoxetine remains the only medication approved for an eating disorder, that being BN. RCTs of antipsychotics in AN have had mixed results; the only agent with some evidence of efficacy is olanzapine. One study suggests dronabinol may induce weight gain in AN. Preliminary studies suggest lack of efficacy of alprazolam, dehydroepiandrosterone, or physiologic estrogen replacement in AN; erythromycin in BN; and the opioid antagonist ALKS-33 in BED. In BED with obesity or overweight, bupropion may cause mild weight loss without seizures, and chromium may improve glucose regulation. Also in BED, three RCTs suggest the stimulant prodrug lisdexamfetamine may reduce binge eating episodes, and another RCT suggests intranasal naloxone may decrease time spent binge eating. There remains a disconnection between the size of eating disorders as a public health problem and the lack of pharmacotherapy research of these conditions.

References

Aug 1, 1991·Psychological Medicine·A Hall, P J Hay
Jan 1, 1985·Journal of Psychosomatic Research·A J Stunkard, S Messick
Jan 1, 1982·Addictive Behaviors·J GormallyD Rardin
Nov 12, 2003·Archives of General Psychiatry·Jose C AppolinarioWalmir Coutinho
May 12, 2005·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·F ProviniP Montagna
Nov 16, 2005·Obesity Research·Alain GolayYves Schutz
May 2, 2006·The American Journal of Psychiatry·John P O'ReardonAlbert J Stunkard
Mar 29, 2007·The Journal of Clinical Psychiatry·Susan L McElroyJames I Hudson
May 24, 2007·International Clinical Psychopharmacology·Francesca BrambillaPalmiero Monteleone
Dec 7, 2007·The American Journal of Psychiatry·Denise E WilfleyUNKNOWN Sibutramine Binge Eating Disorder Research Group
Mar 24, 2011·Psychological Medicine·E AttiaY Wang
Apr 16, 2011·The International Journal of Eating Disorders·James LockDenise Wilfley
Jun 15, 2011·Journal of Child and Adolescent Psychopharmacology·Vivian KafantarisAnil K Malhotra
Jul 12, 2011·The International Journal of Eating Disorders·Anna I GuerdjikovaJames I Hudson
Aug 30, 2011·Journal of the American Academy of Child and Adolescent Psychiatry·Jennifer HagmanMarianne Z Wamboldt
Oct 4, 2011·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Martin AignerUNKNOWN WFSBP Task Force On Eating Disorders
Mar 1, 2012·Physiology & Behavior·Michael J DevlinB Timothy Walsh
Apr 27, 2012·European Eating Disorders Review : the Journal of the Eating Disorders Association·Pauline S PowersWalter Kaye
May 1, 2012·Journal of Clinical Psychopharmacology·Jillon S Vander WalKishore M Gadde
Jul 17, 2012·The Journal of Clinical Psychiatry·Taro KishiChristoph U Correll
Aug 3, 2012·Behavioural Pharmacology·Rebecca L CorwinJan S Ulbrecht
Sep 6, 2012·Expert Opinion on Pharmacotherapy·Susan L McElroyAnne M O'Melia
Sep 25, 2012·The International Journal of Eating Disorders·Jocelyn LebowM Hassan Murad
Feb 6, 2013·The International Journal of Eating Disorders·Susan L McElroyElliot W Ehrich
May 10, 2013·The Journal of Clinical Psychiatry·Marney A White, Carlos M Grilo
May 10, 2013·The International Journal of Eating Disorders·James E MitchellKristine Steffen
Oct 10, 2013·The International Journal of Eating Disorders·Alin AndriesRené Klinkby Støving
Nov 22, 2013·The Annals of Pharmacotherapy·Jamielynn C SebaalyShauna S Garris
Jan 28, 2014·Expert Opinion on Emerging Drugs·Deborah L Reas, Carlos M Grilo
Jun 4, 2014·Eating and Weight Disorders : EWD·Alin AndriesRené Klinkby Støving
Aug 21, 2014·The International Journal of Eating Disorders·Joanna E SteinglassB Timothy Walsh
Nov 8, 2014·Journal of Eating Disorders·Jasmijn de VosJack Dekker

❮ Previous
Next ❯

Citations

Nov 27, 2015·Neuroscience and Biobehavioral Reviews·P SöderstenM Zandian
May 21, 2016·Frontiers in Pharmacology·Alison S PoultonRalph K H Nanan
May 28, 2016·The Nursing Clinics of North America·Barbara E WolfeMeredith R Kells
Aug 2, 2016·Pharmacogenomics·Sarah Smith, Blake Woodside
Jan 20, 2017·The International Journal of Eating Disorders·Alan E KazdinDenise E Wilfley
May 27, 2017·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Michael Lutter
Jan 21, 2018·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Catherine F MoorePietro Cottone
Jun 19, 2018·Psychological Medicine·Katherine SchaumbergCynthia M Bulik
Jul 2, 2019·The British Journal of Psychiatry : the Journal of Mental Science·Joanne C DemmlerJacinta O A Tan
Aug 5, 2017·Current Opinion in Psychiatry·Anja HilbertRicarda Schmidt
Aug 7, 2019·Clinical and Translational Science·Shamir N KalariaMathangi Gopalakrishnan
Mar 31, 2017·The Journal of Clinical Endocrinology and Metabolism·Dennis M StyneJack A Yanovski
Jun 28, 2017·European Journal of Clinical Pharmacology·María Del Mar Alañón PardoFrancisco Morillas Márquez
Jun 8, 2017·Eating and Weight Disorders : EWD·Shae-Leigh C Vella, Nagesh B Pai
Mar 3, 2019·Journal of Clinical Medicine·Corinne BlanchetNathalie Godart
Oct 31, 2020·Frontiers in Psychology·Sahib S KhalsaJustin S Feinstein
Jan 6, 2021·International Journal of Molecular Sciences·Wu Jeong HwangJun Soo Kwon
Jan 29, 2021·European Journal of Pharmacology·Anna Franceschini, Liana Fattore
Feb 5, 2021·Clinical Neuropharmacology·Robert P WilfahrtAbigail Matthews Hamburg
Jul 25, 2021·Journal of Clinical Medicine·Dunja MairhoferAndreas Karwautz
Aug 31, 2021·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Elizabeth SchneiderColin T Dourish

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic-Induced Weight Gain

Antipsychotic-induced weight gain (aiwg) is a common adverse effect of this treatment, particularly with second-generation antipsychotics, and it is a major health problem around the world. Here are the latest discoveries pertaining to AIWG.

Anorexia Nervosa

Anorexia nervosa (AN) is a psychiatric condition characterized by severe weight loss and secondary problems associated with malnutrition. Here is the latest research on AN.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Related Papers

The International Journal of Eating Disorders
M De ZwaanJames Mitchell
The International Journal of Eating Disorders
M De ZwaanJames Mitchell
The International Journal of Eating Disorders
Anna Maria Siega-RizCynthia M Bulik
© 2021 Meta ULC. All rights reserved